On Monday, July 13, I had my latest round of follow-up scans. This set of scans comes five months after my previous update in February, and I am pleased to share that the results show continued stability across the board.
Here is the breakdown of the findings from the radiology report:
1. Continued Liver Metastasis Shrinkage
The metastasis in hepatic segment III, which was treated with SBRT in November 2025, shows a continued decrease in size. This indicates that the targeted radiation treatment continues to be effective in controlling and reducing this specific lesion.
 |
| Liver Lesion Shrunk! |
2. Stability in Existing Pelvic and Perinephric Masses
The right pelvic/sacral mass (the original metastatic tumor from 2019, treated with proton radiation in early 2023) remains stable and unchanged.
 |
| Pelvic/Sacral Mass Stable |
The right perinephric mass (the lesion near my right kidney, treated with proton SBRT in early 2025) also remains stable and unchanged.
 |
| Right Perinephric Mass Stable |
3. No New Disease Progression
There is no evidence of disease progression anywhere in the abdomen or pelvis.
There is no evidence of disease progression in the chest.
Current Status
We are now seven and a half years out from my January 2019 metastatic recurrence. Given the high-grade nature of this myxoid liposarcoma, achieving continued stability across multiple treated areas without any new lesions or chest progression is the best outcome we can hope for on these scan days.
Because everything is holding steady, there are no changes to my current treatment plan. I am still receiving chemotherapy (Doxil) every 6 weeks, which remains my current regimen. We will continue on this path and schedule the next round of routine surveillance scans, likely in about 4 months.
Thank you, as always, for following along and for your continued support.
--Dave
No comments:
Post a Comment